NC
ASND icon

Nexthera Capital’s Ascendis Pharma A/S ASND Stock Holding History

Nexthera Capital’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$6.94M Buy
+60,266
New +$7.21M 5.78% 9
2017
Q1 		– Sell
-100,000
Closed -$2.02M – 38
2016
Q4 		$2.02M Sell
100,000
-46,200
-32% -$923K 1.19% 23
2016
Q3 		$2.94M Buy
+146,200
New +$2.41M 1.81% 17

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Nexthera Capital's ASND Position: Q2 2019 in Review

Nexthera Capital opened a new position in Ascendis Pharma A/S (ASND) in Q2 2019: 60,266 shares worth $6.94M. The stake represents 5.78% of the portfolio and ranks #9 among its holdings. This is a return to the name: Nexthera Capital previously reported a position in ASND as recently as Q4 2016.

Nexthera Capital first reported a position in ASND in Q3 2016 and has held it in 3 quarters since. 132 funds tracked by Wall St. Rank hold ASND as of Q2 2019.

  • Nexthera Capital held 60,266 shares of Ascendis Pharma A/S worth $6.94M as of Q2 2019.
  • Ascendis Pharma A/S was a new Nexthera Capital position in Q2 2019.
  • Ascendis Pharma A/S made up 5.78% of Nexthera Capital's portfolio in Q2 2019, its #9 holding.
  • Nexthera Capital first reported a position in Ascendis Pharma A/S in Q3 2016 and has held it in 3 quarters since.
  • 132 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.